Unlocking New Medicines from Microbial Diversity
Nature remains one of the richest sources of pharmaceuticals, with over 20,000 microbial secondary metabolites identified to date. However, only a fraction of these compounds have made it into drug development pipelines. As synthetic chemical libraries and combinatorial chemistry compete for dominance in drug discovery, natural product research must become more efficient and strategic than…